TRANSCELERATE BIOPHARMA INC
EIN: 46-0886344West Conshohocken, PAZIP: 19428
H99 - Medical Research501(c)(6)
Mission
TRANSCELERATE BIOPHARMA'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT COMMUNITY TO IDENTIFY, PRIORITIZE, DESIGN, AND FACILITATE THE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH-QUALITY DELIVERY OF NEW MEDICINES.MEMBERSHIP IN TRANSCELERATE IS OPEN TO BIOPHARMACEUTICAL COMPANIES WITH RESEARCH & DEVELOPMENT OPERATIONS.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $34.2M | $0 | $48.1M |
Compensation
ANTHONY GARGES
$257,724
$223,018
$0
$534,520
Similar Organizations
WILLS EYE OPHTHALMOLOGY
$32M revenuePhiladelphia, PA
Similar sector (H)Very similar revenue ($32M vs $34.2M)Same state (Pennsylvania)Comparable compensation levels
NRG ONCOLOGY FOUNDATION INC
$32.2M revenuePhiladelphia, PA
Similar sector (H)Very similar revenue ($32.2M vs $34.2M)Same state (Pennsylvania)
CENTRE COUNTY CANCER CENTER
$29.6M revenueState College, PA
Similar sector (H)Similar revenue ($29.6M vs $34.2M)Same state (Pennsylvania)
NSABP FOUNDATION INC
$44.2M revenuePittsburgh, PA
Similar sector (H)Comparable revenue ($44.2M vs $34.2M)Same state (Pennsylvania)
MONELL CHEMICAL SENSES CENTER
$18.8M revenuePhiladelphia, PA
Similar sector (H)Comparable revenue ($18.8M vs $34.2M)Same state (Pennsylvania)
Data from IRS Form 990 filings (2023).